Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Nuvig halts development of lead drug for rare autoimmune disease
While a ph. 2 trial in CIDP has stopped, development in ITP is still ongoing, and Nuvig intends to pursue more diseases with NVG-2089.
Darren Incorvaia
Oct 6, 2026 2:48pm
Novartis pens $7.8B deal for Abogen's in vivo autoimmune TCE
Oct 2, 2026 4:24am
ai3Bio buzzing with $48M for STING pathway targeting pipeline
Sep 29, 2026 9:00am
Amgen fusion protein eases Sjögren's severity in ph. 3 win
Sep 22, 2026 10:20am
Beeline flies into ph. 3 as oral lupus drug soars past placebo
Sep 9, 2026 7:00am
Teva autoimmune antibody notches ph. 2 win in celiac disease
Sep 2, 2026 10:52am
